Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Immunoassay Market Size to Reach USD 55.85 Billion in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

19 Jan, 2023, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, B.C., Jan. 19, 2023 /PRNewswire/ -- The Immunoassay Market size reached USD 39.72 Billion in 2021 and is expected to register a CAGR of 3.9% during the forecast period, according to latest analysis by Emergen Research. Increase in prevalence of chronic diseases, and introduction of technically advanced systems and technologies are some key factors driving dental equipment market revenue growth.

According to the National Diabetes Statistics Report, about 37.3 million individuals in the United States developed diabetes by 2020, with over 96 million adults having pre-diabetes. Furthermore, increased R&D spending by government organizations and pharmaceutical corporations for disorders and diseases such as chronic ailments and diabetes is boosting the global market. According to Pharmaceutical Research and Manufacturers of America, the biopharmaceutical sector would invest an estimated USD 102.3 billion in R&D in 2021.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1507

Drivers:

Technological advancements in immunoassay techniques are leading to an increase in global demand for immunoassay techniques. Recent product introductions by leading industry competitors are also contributing to market growth. For instance, on May 2022, Abbott announced the launch of the HBsAg Next Qualitative solution in India to improve Hepatitis B viral diagnosis (HBV). This test will aid in the improvement of patient outcomes while ensuring the safety of blood supplies. This extremely sensitive chemiluminescent microparticle immunoassay (CMIA) aids in the detection of HBV in human serum and plasma (blood) samples, as well as population screening. A chemiluminescent immunoassay is a biochemical method used in immunology that differs from the usual enzyme immunoassay. Furthermore, on April 2020, the ErbaLisa COVID-19 ELISA kits for the detection of IgG and IgM antibodies to SARS-CoV-2 have been developed by Erba Mannheim. The tests may be run manually or with any open automated ELISA analyzer, like the Erba Mannheim ELAN 30s.

Restraints:

There are some issues and difficulties facing the immunoassay market. One of the significant factors hindering the growth of the market is specificity and false positive results. The presence of other substances in the sample can interfere with the assay, leading to false positive results. Non-specific binding of the antibodies may bind to substances other than the target analyte and can give inaccurate results. The sensitivity of the technique is also a major issue. The assay may not be sensitive enough to detect low levels of the target analyte.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1507

Growth Projections:

The Immunoassay Market is expected to register a CAGR of 3.9% over the forecast period and revenue is projected to increase from USD 39.72 Billion in 2021 to USD 55.85 Billion in 2030. Research and development of immunoassay technique are expected to support revenue growth of the market.

Current Trends and Innovations:

The Immunoassay market is undergoing gradual changes during the forecast period. Immunoassays are laboratory tests that use the principle of antigen-antibody interactions to detect and quantify specific substances in a sample. Over the years, immunoassays have undergone significant developments, and some current trends in the field include Point-of-care (POC) testing, multiplexed assays, microfluidics-based assays, biosensors, Artificial intelligence (AI), and Machine Learning (ML). For instance, multiplexed assays allow for the simultaneous detection of multiple analytes in a single sample, which can increase the efficiency of testing and reduce costs. In addition, microfluidic-based immunoassays are becoming more popular in POC testing and in the field of personalized medicine.

Strategic Initiatives:

Major companies included in the market report are Siemens Healthcare GmbH, Biomérieux, Abbott, Becton Dickinson and Company, Beckman Coulter, Inc., Hologic, Inc., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific.

  • On November 2021, at MEDICA 2021, Boditech Med introduced its new automated immunoassay analyzer, AFIAS-10, which features a blood collection tube and all-in-one cartridge system. The AFIAS-10 is a one-of-a-kind, integrated Sample-to-Answer system that can simultaneously perform 10 different tests for various parameters.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/immunoassay-market

Scope of Research

Report Details

Outcome

Market Size in 2021

USD 39.72 Billion

CAGR (2022–2030)

3.9 %

Revenue Forecast to 2030

USD 55.85 Billion

Base Year for Estimation

2021

Historical Data

2019–2020

Forecast Period

2022–2030

Quantitative Units

Revenue in USD Billion and CAGR in % from 2022 to 2030

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

product, technology, application, end-use, and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

Siemens Healthcare GmbH, Biomérieux, Abbott, Becton Dickinson and Company, Beckman Coulter, Inc., Hologic, Inc., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific

Customization Scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1507

Emergen Research has segmented Immunoassay on the basis of product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2030)
    • Reagents and kits
    • Instruments
  • Technology Type Cycle Outlook (Revenue, USD Billion; 2019-2030)
    • Radioimmunoassay (RIA)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Rapid Test
    • Fluoroimmunoassay (FIA)
    • Chemiluminescence immunoassay (CLIA)
    • Others
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Therapeutic Drug Monitoring
    • Oncology
    • Cardiology
    • Endocrinology
    • Infectious Disease Testing
    • Autoimmune Diseases
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2019-2030)
    • Hospitals
    • Biotechnology & Pharmaceutical Industries
    • Blood Banks
    • Clinical Laboratories
    • Academic Research Centers
    • Others
  • Regional Outlook (Revenue, USD Billion, 2019-2030)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC
    • Latin America
      • Brazil
      • Rest of LATAM
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Turkey
      • Rest of MEA

Latest Research Reports Published by Emergen Research:

Gas Treatment Market, By Type (Amines and Non-Amines), By Application (Dehydration and Acid Gas Removal), and By Region Forecast to 2030

Flight Simulator Market, By Method (Synthetic and Virtual), By Type (Flight Training Devices, Full Flight Simulators, Full Mission Flight Simulators, and Fixed Base Simulators), By Platform (Commercial and Military), and By Region Forecast to 2030

Electronic Flight Instrument System Market, By Platform (Commercial Aviation, Military Aviation, and General Aviation), By Application By Fit (Line-Fit and Retrofit), and By Region Forecast to 2030

Space Cryogenics Market By Cooling Type (High Temperature and Low Temperature Coolers), By Component Type (Low Conductive Supports, Multilayer Insulation, V-Groove Shields), By Application and By Region Forecast to 2030

Smart Shelves Market By Component (Hardware, Software & Solutions, and Professional Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises), By Application, and By Region Forecast to 2030

Connected Toys Market, By Application (Education and Entertainment), By Age Group (1-5 Years, 6-8 Years, 9-12 Years, and Teenagers (13-19 Years)), By Distribution Channel (Online and Offline), and By Region Forecast to 2030

Negative Pressure Wound Therapy Market, By Product Type (Conventional NPWT, Single-Use NPWT, and Accessories), By Wound Type, By End-Use, and By Region Forecast to 2030

Hypercholesterolemia Market, By Disease Type (Genetic and Acquired), By Treatment Type (Statins, Bile-acid Binding Resins, Niacin, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com 
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-immunoassay-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.